2011 Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | < 1999

  • Axerio-Cilies P., See R.H., Zoraghi R., Worral L., Lian T., Stoynov N., Jiang J., Kaur S., Jackson L., Gong H., Swayze R., Amarandoron E., Kumar N.S., Moreau A., Hsing M., Strynadka N.C., McMaster W.R., Finlay B.B., Foster L.J., Young R.N., Reiner N.E., Cherkasov A. (Feb) 2011. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase. ACS Chem. Biol. 2012 Feb 17;7(2):350-9.
  • Willing B.P., Vacharaksa A., Croxen M., Thanachayanont T., Finlay, B.B. (Oct) 2011. Altering host resistance to infections through microbial transplantation. PLoS One, 2011;6(10):e26988.
  • Zoraghi R., Warroll L., See R.H., Strangman W., Popplewell W.l., Gong H., Samaai T., Swayze R.D., Kaur S. Vuckovic M., Finlay B.B. (Dec) 2011. MRSA puruvate kinase as a target for bis-indole alkaloids with antibacterial activities. J Biol Chem. 2011 Dec 30;286(52):44716-25.
  • Brown N.F., Finlay B.B. (Jul) 2011. Potential origins and horizontal transfer of type III secretion systems and effectors. Mob Genet Elements. 2011 Jul;1(2). 118-121.
  • Auweter S., Yu H.B., Arena E.T., Guttman J.A., Finlay B.B. (Sept) 2011. Oxysterol-binding protein (OSBP) enhances replication of intracellular Salmonella and binds the Salmonella SPI-2 effector SseL via its N-terminus. Microbes Infect. 2012 Feb;14(2):148-54.
  • Shames S.R., Croxen M.A., Deng W., and Finlay B.B. (Sept) 2011. The type-III secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane (TIM) 17b. Infect Immun, 2011 Dec;79(12):4784-90.
  • Schreiber F., Lynn D.J., Houston A., Peters J., Mwafulirwa G., Finlay B.B., Brinkman F.S., Hancock R.S., Dougan G., Gordon M.A. (Oct) 2011. The Human Transcriptome during Nontyphoid Salmonella and HIV Coinfection Reveals Attenuate NFKB-Mediated Inflammation and Persistent Cell Cycle Disruption. J Infect Dis. 2011 Oct;204(8):1237-45.

  • Shames S.R., Finlay B.B. (Mar) 2011). Proteolytic Cleavage of NF-KBp65: A Novel Mechanism for Subversion of Innate Immune Signaling by Pathogenic E. coli. Front Microbiol. 2011;2:38.
  • Arena E.T., Auweter S.D., Antunes L.C., Vogl A.W., Han J., Guttman J.A., Croxen M.A., Menendez A., Covey S.D., Borchers C.H., Finlay B.B. (Aug) 2011. The deubiquitinase acivity of the Salmonella Pathogenecity Island 2 effector, SseL, prevents accumulation of cellular lipid droplets. Infect Immun. 2011 Nov;79(11):4392-400.
  • Gill N., Finlay B.B. (Aug) 2011.The gut microbiota: challenging immunology. Nat Rev Immunol. 2011 Aug 26;11(10):636-7.
  • Oviedo-Boyso J., Cortes-Vieyra R., Huante-Mendoza A., Yu H.B., Valdez-Alarcon J.J., Bravo-Patino A., Cajero-Juarez M., Finlay B.B., Baizabel-Aguirre V.M. (Aug) 2011. The P13K-Akt signaling pathway in important for Staphulococcus aureus internalization by endothelial cells. Infect Immun. 2011 Nov;79(11):4569-77.
  • Shames S.R., Bhavsar A.P., Croxen M.A., Law R.J., Mak S.H., Deng W., Li Y., Bidshari R., de Hoog C.L., Foster L.J., Finlay B.B. (Oct) 2011. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cell Microbiol. 2011 Oct;13(10):1542-57.

  • Biemans-Oldehinkel E., Sal-Man N., Deng W., Foster L.J., Finlay B.B. (Oct) 2011. Quantitative proteomic analysis reveals formation of an EscL-EscQ-EscN Type III Complex in Enteropathogenic E. coli. (Jul) 2011. J. Bacteriol. 2011 Oct;193(19):5514-9.
  • Antunes L.C., Andersen S.K., Menendez A., Arena E.T., Han J., Ferreira R.B., Borchers C.H., Finlay B.B. (Sept) 2011. Metabolomics reveals phospholipids as important nutrient sources during Salmonella growth in bile in vitro and in vivo.  J Bacteriol. 2011 Sep;193(18):4719-25.
  • Sham H.P., Shames S.R., Croxen M.A., Ma C., Chan J.M., Khan M.A., Wickham M.E., Deng W., Finlay B.B., Vallance B.A.  (Sept) 2011. Attaching and Effacing Bacterial Effector NleC suppresses epithelial inflammatory responses by inhibiting NF-{kappa}B and p38Mitogen-activated Protein Kinase Activation.  Infect. Immun. 2011 Sep;79(9):3552-62
  • Allen K.J., Rogan D., Finlay B.B., Potter A.A., Asper D.J. (Apr) 2011. Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157. Can J Vet Res. 2011 Apr;75(2):98-105.
  • Buckner M.M., Croxen M., Arena E.Y., Finlay B.B. (May) 2011. A comprehensive study of the contribution of Salmonella enteric serovar Typhimurium SP12 effectors to bacterial colonization, survival, and replication in typhoid fever, macrophage, and epithelial cell infection models. Virulence. 2011 May 1;2(3):208-16.
  • Ferreira R.B., Willing B.P., Finlay B.B. (May) 2011. Bringing Koch’s Postulates To The Table In IBD. Cell Host Microbe. 2011 May 19;9(5):353-4.
  • Gal-Mor O., Elhadad D., Deng W., Rahav G., Finlay B.B. (May) 2011. The Salmonella enterica PhoP Directly Activates the Horizontally Acquired SPI-2 Gene sseL and is Functionally Different from a S. bongori Ortholog. PLoS One. 2011;6(5):e20024.
  • Auweter S.D., Bhavsar A.P., de Hoog C.L., Li Y., Chan Y.A., van der Heijden J., Lowden M.J., Coombes B.K., Rogers L.D., Stoynov N., Foster L.J., Finlay B.B. (May) 2011. Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners. J Biol Chem. 2011 Jul 8;286(27):24023-35.
  • Kum W.W., Lo B.C., Yu H.B., Finlay B.B. (May) 2011. Protective Role of Akt2 in Salmonella enterica Serovar Typhimurium-Induced Gastroenterocolitis. Infect Immun. 2011 Jul;79(7):2554-66.
  • Buckner M.M., Finlay B.B. (Apr) 2011. Host-microbe interaction: Innate immunity cues virulence.  Nature. 2011 Apr 14;472(7342):179-80.
  • Antunes, C.M., Finlay, B.B. (Mar) 2011. A comparative analysis of the effect of antibiotic treatment and enteric infection on intestinal homeostasis. Gut Microbes, 2011 Mar1;2(2):105-8.
  • Sal-Man N., Croxen M.A., and Finlay B.B. (May) 2011. Translocation of effectors – revisiting the injectosome model. Fut Microbiol. 2011 May;6:483-4.
  • Brown N., Coombes B.K., Bishop J.L., Wickham M.E., Lowden M.J., Gal-Mor O., Boyle E.C., Sanderson K.L., Finlay B.B. (Mar) 2011. Salmonella phage ST64B encodes a member of the SseK/NleB effector family. PLoS ONE, 2011 Mar 18;6(3):e17824.
  • Willing B.P., Antunes L.C., Keeney K.M., Ferreira R.B., Finlay B.B. (June) 2011. Harvesting the biological potential of the human gut microbiome. Bioessays. 2011 Jun;33(6):414-8.
  • Shames S.R. and Finlay B.B. (Mar) 2011. Proteolytic cleavage of NF-κB p65: a novel mechanism for subversion of innate immune signaling by pathogenic E. coli. Front. Microbiol. 2011;2:38.
  • Antunes L.C., Davies J.E., Finlay B.B. (Feb) 2011. Chemical signaling in the gastrointestinal tract.  F1000 Biol Rep. 2011 Feb 1;3:4.
  • Gill N., Wlodarska M., Finlay B.B. (Mar) 2011. Roadblocks in the gut: barriers to enteric infection. Cell Microbiol. 2011 Mar 10;13(5):660-9. [abstract]
  • Willing B.P., Russell S.L., Finlay B.B.  (Apr) 2011. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol. 2011 Apr;9(4):233-43. [abstract]
  • Zoraghi R., See R.H., Axerio-Cilies P., Kumar N.S., Gong H., Moreau A., Hsing M., Kaur S., Swayze R.D., Worrall L., Amandoron E., Lian T., Jackson L., Jiang J., Thorson L., Labriere C., Foster L., Brunham R.C., McMaster W.R., Finlay B.B., Strynadka N.C., Cherkasov A., Young R.N., Reiner N.E. (May) 2011.  Identification of Methicillin Resistant Staphylococcus aureus Pyruvate Kinase as a Novel Antimicrobial Drug Target. Antimicrob Agents Chemother. 2011 May;55(5):2042-53. [abstract]
  • Wlodarska M., Willing B., Keeney K.M., Menendez A., Bergstrom K.S., Gill N., Russell S.L., Vallance B.A., Finlay BB.  (Feb) 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011 Apr;79(4):1759-69.  Kim Barrett: Faculty of 1000 3 Mar 2011.  /http://f1000.com/8671966
  • Antunes, C., Arena E.T., Menendez A., Han J., Ferreira R.B., Buckner M.M., Lolic P., Madilao L.L., Bohlmann J., Borchers C.H., Finlay, B.B. (Feb) 2011. The impact of Salmonella infection on host hormone metabolism revealed by metabolomics. Infect Immun. 2011 Apr;79(4):1759-69.
  • Antunes L.C., Han J., Ferriera R.B., Lolic P., Borchers C.H., Finlay B.B. (Feb) 2011. The effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother. 2011 Apr;55(4):1494-503
  • Antunes, L.C.M., Davies J.E., Finlay B.B. (Jan) 2011. Mining Bacterial Small Molecules. The Scientist 2011 Jan vol 25;1, includes cover.
  • Finlay B.B., Bonas U. H. (Jan) 2011. Host-microbe interactions: ever increasing complexity. Curr Opin Microbiol. 2011 Jan 14.
  • Tourret J., Finlay B.B. (Jan) 2011. A Receptor for Minigococcus: Eliciting ß-Arrestin Signaling for Barrier Breaching. Dev Cell. 2011 Jan 18;20(1):7-8.
  • Keeney K.M., Finlay B.B. (Feb) 2011. Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut.  Curr. Opin. Microbiol. 2011 Feb;14(1):92-8.
  • Ferreira R.B., Antunes, L.C., Finlay B.B. (Nov) 2010. Should the human microbiome be considered when developing vaccines? PLoS Pathog. 2010 Nov 18;6(11):e1001190.
  • Ferreira, R., Gill N., Willing B.P., Antunes L.C., Russell S.L., Croxen M.A., Finlay, B.B. 2011. The Intestinal Microbiota plays a role in Salmonella-Induced Colitis Independent of Pathogen Colonization. PloS One. 2011;6(5):e20338.